Table of Contents
Volume 4 | Issue 1
Publication Date: June 2005
Abstract
No Access
Pay-Per View
Full Text
Add to Cart
Editorial | ||
 5-6 |
Prostate-Specific Antigen Endpoints in Hormone-Refractory Prostate Cancer Oliver Sartor, Daniel George |
|
Meeting Highlights | ||
7-14 |
Highlights from: the 41st Annual Meeting of the American Society of Clinical Oncology; May 2005 and the 2005 American Society of Clinical Oncology Prostate Cancer Symposium; February 2005; Orlando, Florida G. Kesava Reddy, Preeta Tyagi, Arif Hussain, Vinay K. Jain, Oliver Sartor |
|
Comprehensive Reviews | ||
15-23 |
Patient Preferences in Prostate Cancer: A Clinician’s Guide to Understanding Health Utilities Karen M. Kramer, Charles L. Bennett, A. Simon Pickard, E. Allison Lyons, Michael S. Wolf, June M. McKoy, Sara J. Knight |
|
24-30 |
The “Emigration, Migration, and Immigration” of Prostate Cancer Kenneth J. Pienta, Robert Loberg |
|
31-37 |
Clinical Benefit of Zoledronic Acid for the Prevention of Skeletal Complications in Advanced Prostate Cancer Fred Saad |
|
38-44 |
Treating the Biochemical Recurrence of Prostate Cancer After Definitive Primary Therapy John F. Ward, Judd W. Moul |
|
45-49 |
Active Surveillance for Prostate Cancer with Selective Delayed Definitive Therapy James A. Eastham |
|
Original Contributions | ||
50-54 |
Absence of Lower Urinary Tract Symptoms is an Independent Predictor for Cancer at Prostate Biopsy, but Prostate-Specific Antigen is Not: Results from a Prospective Series of 569 Patients Christopher R. Porter, Kalyan C. Latchamsetty, Christopher L. Coogan, Jason Kim |
|
55-60 |
Antigen-Presenting Cells 8015 (Provenge®) in Patients with Androgen-Dependent, Biochemically Relapsed Prostate Cancer Garth Beinart, Brian I. Rini, Vivian Weinberg, Eric J. Small |
|
Case Report | ||
61-64 |
Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy William K. Oh, Daniel J. George, Miah-Hiang Tay |
|
